Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2025-03-31
• Last 15 days FTD volume: ₹0.07 M
• Last 3 months FTD volume: ₹4.1 M
• Last year FTD volume: ₹4.1 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx Pharmaceutical RARE	₹1.59 M	₹5.65 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	₹0.73 M	₹23.81 M	🇺🇸 USA
Pfizer PFE	₹33.22 M	₹0.35 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	₹23.26 M	₹51.47 M	🇺🇸 USA
Amicus Therapeutics FOLD	₹0.82 M	₹5 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	₹2.03 M	₹8.19 M	🇺🇸 USA